The Anaphylaxis Manifesto, spearheaded by the Global Allergy and Asthma European Network and the European Federation of Allergy and Airways Diseases Patients’ Associations, outlines ten critical actions needed to enhance the lives of individuals at risk of severe allergic reactions.
Food allergies are a significant focus, given their prominence as a common cause of anaphylaxis. However, the Manifesto also highlights other allergenic triggers and underscores the need for integrated care pathways, public awareness, and stronger legislative measures. Broader aspects, such as the triggers, management, and prevention of anaphylaxis, are also addressed.
The ten priorities outlined in the Manifesto are grouped into three key themes:
- Increasing Awareness: Engaging stakeholders to prevent and manage serious allergic reactions.
- Improving Treatment Access: Ensuring availability of effective treatments and building user confidence in their application.
- Enhancing Long-Term Support: Implementing multi-faceted approaches to provide comprehensive support for individuals at risk.
The authors emphasise that these priorities are not new; they have been identified in previous guidelines and studies as essential actions. The Manifesto, therefore, serves as a global call to action, urging consumer organisations, healthcare institutions, governments, researchers, and the food industry to work together to address these urgent needs.
The development of this manifesto united experts worldwide, spanning Europe, Canada, Australia and the US. The 12-person working group comprised representatives from patient organisations, allergy specialists, immunologists, paediatricians, educators, primary care, researchers and others who oversaw the process to build consensus on consumer-centric advocacy priorities. The working group consulted directly with over 200 organisations representing thousands of stakeholders and a panel of 67 international experts reviewed and signed off the priorities.
Reference: Muraro, A., et al. (2024). 10 practical priorities to prevent and manage serious allergic reactions: GA2LEN ANACare and EFA Anaphylaxis Manifesto. Clinical and Translational Allergy, 14(12), e70009. Available at: https://doi.org/10.1002/clt2.70009
